_ About us Our history Our global family Our responsibility Our responsibility Grants Kowa Pharmaceutical Europe Co. Ltd. (KPE) regularly receives requests for monetary grants to support a range of activities by professional healthcare organisations. These unrestricted grants are provided to support such activities as research where Kowa is not directly involved, Independent Medical Education Programmes or attendance of the organisations healthcare professionals at medical or scientific meetings where it may be used to cover expenses. Show more Payments to healthcare professionals and healthcare organisations: Healthcare professionals (HCPs) and Healthcare organisations (HCOs) provide a number of services to KPE, based on their clinical knowledge or knowledge of healthcare systems and healthcare management. Show more Previous years Payments made by Kowa Pharmaceutical Europe Co. Ltd. (KPE) to European Healthcare Professionals in 2019 totalled £0.00 and payments to Healthcare Organisations totalled £0.00. Show more Hospitality and promotional expenditure In the course of our usual business we must interact with HCPs and provide in some instance’s hospitality. This hospitality and these interactions are highly regulated and are governed by the local Marketing Code of Practice. We commit that our promotional practices are ethical and in line with UK and European marketing codes and that we will not enter into any promotional activity for unapproved medicines or for unapproved uses of our medicines. Our business practices prohibit the offering of any bribe, kick back or inducement to any government official or any other person in return for a service. Show more The bribery Act 2011 KPE requires that all of its staff and those of third parties acting on its behalf comply with all anti-corruption legislation and act with the highest ethical standards. Show more Tax strategy for Kowa group operations in the United Kingdom Scope Kowa Group is a complex corporate entity that consists of many associated companies and engages in diverse business activities. At the group’s pinnacle is Kowa Company Ltd., which is based in Nagoya, Japan. With a history of over 100 years since being founded in 1894, Kowa has continually made progress based on both the discipline of manufacturing and the challenges of enterprise. The group aims to pursue the happiness of people throughout the world and help them achieve healthy and prosperous lifestyles. Kowa aims to continue to provide new and better products and services through its global network. Show more Kowa Pharmaceutical Europe Co. Ltd. 105 Wharfedale Road Winnersh Triangle Wokingham Berkshire, RG41 5RB CONTACT US Our products Livazo Avansee Research & development Pipeline Pemafibrate K-877 Ripasudil K-321 Adverse event reporting Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products. REPORT ADVERSE EVENT Copyrights © 2020 Kowa Pharmaceutical Europe Co. Ltd. All rights reserved. Date of preparation: 11 / 2020 UIN: KPE20 00002 Privacy policy Cookie policy Terms of use